A NEUROPHARMACOLOGICAL INVESTIGATION ON HALLUCINOGENIC DRUGS. LABORATORY RESULTS VERSUS CLINICAL TRIALS.
D000661:Amphetamine; D000662:Amphetamines; D000818:Animals; D001362:Avoidance Learning; D001921:Brain / Q000502:physiology*; D002490:Central Nervous System; D002746:Chlorpromazine; D003213:Conditioning, Psychological; D004193:Discrimination Learning; D004569:Electroencephalography; D004594:Electrophysiology; D006213:Hallucinogens; D007858:Learning; D008238:Lysergic Acid Diethylamide; D010600:Pharmacology; D011817:Rabbits; D012106:Research; D012601:Scopolamine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
D000661:Amphetamine; D000662:Amphetamines; D002746:Chlorpromazine; D006213:Hallucinogens; D008238:Lysergic Acid Diethylamide; D012601:Scopolamine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
AMPHETAMINE; AVOIDANCE LEARNING; BRAIN ELECTROPHYSIOLOGY; CENTRAL NERVOUS SYSTEM; CHLORPROMAZINE; CONDITIONING (PSYCHOLOGY); DISCRIMINATION LEARNING; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL LAB STUDY; HALLUCINOGENS; LEARNING; LYSERGIC ACID DIETHYLAMIDE; PHARMACOLOGY; RABBITS; SCOPOLAMINE; SEROTONIN INHIBITORS